机会性输卵管切除术预防卵巢癌的成本效益
研究构建两个模型,分别模拟45岁女性腹腔镜子宫切除保留卵巢和35岁女性腹腔镜永久避孕时行机会性输卵管切除术与常规诊疗的成本效益。子宫切除队列中机会性输卵管切除术节省费用,避孕队列中ICER为每QALY 31432美元且具成本效益。结论认为对低风险盆腔手术女性可能具成本效益,子宫切除时优势更大。
要点
- 永久避孕队列中机会性输卵管切除术ICER为每QALY 31432美元,只要降低卵巢癌风险54%即保持成本效益。
- 蒙特卡洛模拟显示子宫切除和永久避孕队列具成本效益的比例分别为62.3%和55%。
核心结论
- 对接受盆腔手术的低风险女性,机会性输卵管切除术可能是降低卵巢癌风险的成本效益策略。
- 在本模型中,两种手术中输卵管切除术均具成本效益,但子宫切除时优势更大。
研究设计与样本
- 研究创建两个模型比较输卵管切除术与常规诊疗的成本效益。
- 假设研究人群为50000名45岁因良性指征行腹腔镜子宫切除并保留卵巢的女性。
- 另假设研究人群为300000名35岁行腹腔镜永久避孕的女性。
- 卵巢癌病例和死亡概率采用SEER数据,风险降低、并发症率、效用值和相关费用来自已发表文献。
- 进行敏感性分析和蒙特卡洛模拟,计算增量成本效果比(ICER)以确定每获得一个质量调整生命年(QALY)的成本。
主要发现
- 腹腔镜永久避孕队列中,与输卵管结扎相比,机会性输卵管切除术ICER为每QALY 31432美元。
- 只要降低卵巢癌风险54%,机会性输卵管切除术在永久避孕队列中即保持成本效益。
- 蒙特卡洛模拟显示子宫切除和永久避孕队列具成本效益的比例分别为62.3%和55%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Data suggesting a link between the fallopian tube and ovarian cancer have led to an increase in rates of salpingectomy at the time of pelvic surgery, a practice known as opportunistic salpingectomy (OS). However, the potential benefits, risks and costs for this new practice are not well established. Our objective was to assess the cost-effectiveness of opportunistic salpingectomy at the time of laparoscopic permanent contraception or hysterectomy for benign indications. METHODS: We created two models to compare the cost-effectiveness of salpingectomy versus usual care. The hypothetical study population is 50,000 women aged 45 undergoing laparoscopic hysterectomy with ovarian preservation for benign indications, and 300,000 women aged 35 undergoing laparoscopic permanent contraception. SEER data were used for probabilities of ovarian cancer cases and deaths. The ovarian cancer risk reduction, complication rates, utilities and associated costs were obtained from published literature. Sensitivity analyses and Monte Carlo simulation were performed, and incremental cost-effectiveness ratios (ICERs) were calculated to determine the cost per quality adjusted life year (QALY) gained. RESULTS: In the laparoscopic hysterectomy cohort, OS is cost saving and would yield $23.9 million in health care dollars saved. In the laparoscopic permanent contraception cohort, OS is cost-effective with an ICER of $31,432/QALY compared to tubal ligation, and remains cost-effective as long as it reduces ovarian cancer risk by 54%. Monte Carlo simulation demonstrated cost-effectiveness with hysterectomy and permanent contraception in 62.3% and 55% of trials, respectively. CONCLUSIONS: Opportunistic salpingectomy for low-risk women undergoing pelvic surgery may be a cost-effective strategy for decreasing ovarian cancer risk at time of hysterectomy or permanent contraception. In our model, salpingectomy was cost-effective with both procedures, but the advantage greater at time of hysterectomy.
引用
- Dilley SE, Havrilesky LJ, Bakkum-Gamez J, et al. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention. Gynecol Oncol. 2017. PMID: 28577884. doi:10.1016/j.ygyno.2017.05.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。